
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Between MOC, your workload, your stress levels, and other job demands, morale was another "pain point" that we heard loud and clear in our annual Issues and Attitudes survey.






